Skip to main content
Canadian Respiratory Journal logoLink to Canadian Respiratory Journal
. 2006 Mar;13(2):83–88. doi: 10.1155/2006/407609

Hypercalcemia in patients with newly diagnosed tuberculosis in Abuja, Nigeria

EA Dosumu 1,, JA Momoh 2
PMCID: PMC2539012  PMID: 16550265

Abstract

BACKGROUND

The prevalence of hypercalcemia has not previously been determined in newly diagnosed tuberculosis (TB) patients in Nigeria.

OBJECTIVE

To determine the incidence of hypercalcemia in Nigerian patients with newly diagnosed TB before the commencement of anti-TB treatment.

METHODS

The present study is a prospective examination of consecutive patients with newly diagnosed TB confirmed by bacteriological and/or histological methods at the National Hospital (Abuja, Nigeria) from January 2004 to December 2004.

RESULTS

Of 120 patients (70 males and 50 females), 70 had pulmonary TB, 10 had pulmonary and pleural TB, 20 had pleural TB without radiographic evidence of lung involvement, 18 had various other forms of extrapulmonary TB and two had disseminated TB. The mean age of the patients was 38.3±12.0 years. The mean albumin-adjusted serum calcium concentration was 2.53±0.22 mmol/L. Hypercalcemia was present in 27.5% of the patients, but only 12% of these patients showed symptoms of hypercalcemia. The type of TB and, in the case of pulmonary TB, the extent of lung involvement, had no effect on the serum calcium concentration.

CONCLUSION

Hypercalcemia is not uncommon among Nigerian patients with newly diagnosed TB, but it is rarely symptomatic.

Keywords: Albumin-adjusted serum calcium, Newly diagnosed, Tuberculosis


The association between tuberculosis (TB) and hypercalcemia is well recognized (15). However, this association has not been determined and documented in Nigeria. The incidence of hypercalcemia in cases of TB varies widely among countries, probably due to differences in vitamin D and calcium intake, the amount of sun exposure, the extent of disease and the criteria for hypercalcemia (511). In the United States (3) and India (12), longitudinal studies that did not correct for patients with hypoproteinemia indicate that 16% to 28% of TB patients may develop hypercalcemia. Hypoalbuminemia is, however, common in patients with active TB, and if the serum calcium concentration is not corrected for a low serum albumin concentration, hypercalcemia may not be recognized (5). Prevalence rates of hypercalcemia ranging from 15% to 51% have been reported in studies that corrected the serum calcium for hypoalbuminemia (4,5,10).

There has been no report of serum calcium concentrations in patients with newly diagnosed TB from Nigeria, a country with a high endemicity of TB. In Malaysia, reports of the prevalence of hypercalcemia in TB patients have varied (2.3% reported by Tan et al [13] and 27.5% reported by Liam et al [14]). The aim of the present study was to determine the incidence of hypercalcemia in newly diagnosed TB patients before anti-TB treatment in Nigeria.

PATIENTS AND METHODS

The present study was conducted at the National Hospital in Abuja, the federal capital of Nigeria. The population of Abuja and, hence, the population of patients in the present study, is a good reflection of the various ethnic groups in Nigeria. Recruitment into the federal civil service is determined by use of a quota system, with all of the states of the federation equally represented. The allocation of houses in Abuja is also determined by using a quota system, with all of the states having equal representation. A look at the distribution of the patients for the present study showed that all the six geopolitical zones in Nigeria were represented. One can therefore argue that the findings in TB patients seen at the National Hospital in Abuja will likely be representative of all patients in Nigeria. Consecutive patients who were newly diagnosed with TB confirmed by bacteriological and/or histological methods, and who presented as either inpatients or outpatients at the National Hospital from January 2004 to December 2004, were studied. The study was approved by the ethics and research committee of the hospital.

The diagnosis of TB was based on one or more of the following criteria in the relevant tissue or specimen: first, a positive smear for acid-fast bacilli; second, a positive culture for Mycobacterium tuberculosis; and third, a typical histology showing the central area of caseation necrosis with epithelioid granulomas with or without positive staining for acid-fast bacilli. Patients who met only the first criterion (and/or the third) had to show clinical and radiological improvement with anti-TB chemotherapy. Patients with hyperparathyroidism and other known calcium metabolism disorders were excluded from the study.

Blood specimens were taken with minimal venostasis before each treatment for the measurement of total serum calcium, albumin, phosphate and alkaline phosphatase by a multichannel automated analyzer. Calcium measurement was performed for each patient as soon as the diagnosis of TB was made based on the stated criteria. An anti-TB regimen was started immediately in confirmed patients. Patients on calcium-containing drugs or vitamin supplements were excluded from the study. The multichannel automated analyzer used in the study was routinely calibrated according to the manufacturer’s specifications throughout the study period. To allow for protein binding of calcium, measured total serum calcium concentrations were corrected for serum albumin concentrations to the midpoint of the serum albumin reference range (34 g/L to 46 g/L) by adding or subtracting 0.025 mmol/L of calcium for each 1 g/L of serum albumin short of or in excess of 40 g/L, assuming that 0.025 mmol of calcium is bound per gram of albumin (15). Only the results of the albumin-adjusted total serum calcium are presented. Hypercalcemia was considered present if the albumin-adjusted total serum calcium concentrations were above the normal range of 2.10 mmol/L to 2.62 mmol/L. The plain chest radiographs taken at the time of presentation, before commencement of anti-TB treatment, were graded on a scale of 1 to 6 to assess the extent of pulmonary disease (16).

Eighty-five patients, who were treated as inpatients or out-patients at the hospital for non-TB respiratory diseases during the study period, had their serum albumin and calcium measured as controls. Those with conditions known to affect calcium metabolism were excluded from the control group. Results are expressed as means ± SD. Significant differences between groups were assessed by using unpaired Student’s t test for continuous variables and the χ2 test for proportions. Correlation coefficients between variables were determined by simple regression analysis. The Newman-Keuls multiple comparisons test was used to determine whether the type of TB and the extent of pulmonary TB had any effect on serum calcium concentration. P<0.05 was considered statistically significant.

RESULTS

During the study period, TB was diagnosed and confirmed in 120 patients (70 males and 50 females) at the National Hospital. The mean age of the patients was 38.3±12.0 years (range 16 to 60 years). The distribution of the types of TB and the number of patients with each type are shown in Table 1. The methods to confirm the diagnosis of TB are summarized in Table 2. The extent of lung involvement, as shown by radiography, in patients with pulmonary TB was grade 2 in four of 70 patients, grade 3 in 28 of 70 patients, grade 4 in 28 of 70 patients, grade 5 in nine of 70 patients and grade 6 in one of 70 patients. The mean serum albumin concentration at the time of diagnosis was 30±7 g/L (range 12 g/L to 46 g/L). Hypoalbuminemia (ie, a serum albumin concentration less than 34 g/L [the lower limit of normal in the authors’ laboratory]) was present in 83 patients (69%) at diagnosis before commencement of anti-TB treatment. Serum albumin had a negative correlation with the patient’s age (r=–0.21, P=0.02) and the extent of lung involvement in the case of pulmonary TB (r=–0.30, P=0.01).

TABLE 1.

Type of tuberculosis

Type Patients (n)
Pulmonary 70
Pulmonary and tuberculous pleural effusion 10
Extrapulmonary 0
Pleural 20
Spinal 5
Lymph node 10
Pericardial 3
Disseminated 2
Total 120

TABLE 2.

Confirmation of tuberculosis diagnosis

Method of tuberculosis confirmation* Patients (n)
Sputum smear and culture positive 50
Bronchial washing smear and culture positive 5
Bronchial washing smear negative but culture positive 8
Bronchial biopsy positive 8
Pleural biopsy positive 32
Lung biopsy positive 11
Liver biopsy positive 3
Lymph node biopsy positive 10
Pericardial biopsy positive 3
*

Bacteriological confirmation was obtained by a positive smear for acid- and alcohol-fast bacilli, or a positive culture for Mycobacterium tuberculosis, or a biopsy showing a central area of caseation necrosis with epitheloid granulomas with or without the presence of acid-fast bacilli

The distribution of albumin-adjusted serum calcium concentrations in patients with TB is shown in Table 3. The mean measured serum calcium was 2.28±0.21 mmol/L (range 1.78 mmol/L to 3.26 mmol/L). A positive correlation was found between the serum albumin and measured serum calcium concentrations (r=0.39, P<0.001). The mean albumin-adjusted serum calcium concentration before treatment was 2.53±0.22 mmol/L (range 2.13 mmol/L to 3.64 mmol/L). Only 63 of 120 patients were confirmed by culture. No statistically significant difference (P<0.001) in the albumin-adjusted serum calcium concentration was found between culture-positive patients and patients who were not culture-positive. Pretreatment hypercalcemia was present in 33 patients (27.5%). Age and sex distribution had no effect on the albumin-adjusted serum calcium concentrations.

TABLE 3.

Distribution of albumin-adjusted serum calcium in patients with tuberculosis

Serum calcium (mmol/L) Patients (n)
2.13–2.22 5
2.23–2.32 10
2.33–2.42 20
2.43–2.52 27
2.53–2.62 24
2.63–2.72 18
2.73–2.82 7
2.83–2.92 4
2.93–3.02 1
3.03–3.12 1
3.13–3.22 2
3.23–3.62 0
3.63–3.72 1

The diagnoses of the 85 control subjects were pneumonia (30 patients), bronchial asthma (28 patients), chronic obstructive pulmonary disease (16 patients), obstructive sleep apnea syndrome (10 patients) and lung cancer without extrathoracic metastasis (one patient). The mean serum albumin concentration in the control group was 36±5 g/L (range 16 g/L to 49 g/L), which was significantly higher than in the TB patients (P<0.001), whereas their albumin-adjusted serum calcium concentration was 2.38±0.09 mmol/L (range 2.10 mmol/L to 2.50 mmol/L), which was significantly lower than that in the TB patients (P<0.001).

The types of TB and the serum calcium concentrations are shown in Table 4. The mean serum calcium concentration was highest in patients with disseminated TB, followed by those who had pulmonary TB with TB pleural effusion. However, the differences in the serum calcium concentration among the different types of TB were not statistically significant. In pulmonary TB, the extent of lung involvement did not have any significant effect on the serum calcium concentration; however, serum calcium concentrations tended to be higher in cases with more extensive chest radiographic changes.

TABLE 4.

Types of tuberculosis and albumin-adjusted serum calcium

Type of tuberculosis Patients (n) Albumin-adjusted serum calcium ± SD (mmol/L)
Pulmonary 70 2.55±0.18
Pulmonary and pleural effusion 10 2.64±0.21
Pleural 20 2.50±0.22
Extrapulmonary other than pleural 18 2.46±0.23
Disseminated 2 2.68±0.44

Newman-Keuls multiple comparisons test (not significant)

Only four (12%) of the hypercalcemic patients had symptoms of hypercalcemia (Table 5), which included polyuria, polydipsia and constipation. All the symptomatic hypercalcemic patients received fluid hydration, and only patient 1 (see Table 5) needed a short course of systemic corticosteroid to bring down the serum calcium concentrations. The mean albumin-adjusted serum calcium of patients with symptomatic hypercalcemia was higher at 3.16±0.35 mmol/L than the mean of those with asymptomatic hypercalcemia at 2.74±0.13 mmol/L; however, this difference was not statistically significant (P=0.99). Patients with asymptomatic hypercalcemia (mean age 35.0±10.0 years) were not significantly older than those without asymptomatic hypercalcemia (mean age 30.0±12.2 years, P=0.29).

TABLE 5.

Patients with symptomatic hypercalcemia

Patient Sex/age (years) Type of tuberculosis Albumin-adjusted serum calcium (mmol/L)
1 F/58 Disseminated 3.65
2 M/40 Disseminated 3.18
3 M/50 Pulmonary 2.89
4 F/40 Lymph node 2.95

F Female; M Male

DISCUSSION

Several investigators (35,12,14) have also confirmed the observation, as in the present study, that hypercalcemia is not uncommon in patients with active TB, but is often mild and asymptomatic in most cases. In the present study, 27.5% of patients had hypercalcemia. This is comparable with the 28% noted by Abbasi et al (3) in the United States, higher than the 15% noted in Hong Kong (10) and the 16% reported from India (12) but lower than the 48% reported from Greece (4) and the 51% from Australia (5). None of the hypercalcemic patients with pulmonary TB had symptoms related to hypercalcemia in the study from India (12).

In the present series, four patients (12%) had symptoms of hypercalcemia that were serious enough to require specific treatment, which included rehydration and steroids. This observation has been reported by others (2,5,17). In a study from Hong Kong (18), only two of 318 patients with active TB had hypercalcemia severe enough to warrant specific treatments such as hydration and a course of steroids. In a study from Malaysia (14), 12% were reported to require treatment for hypercalcemia, as observed in the present series. Another report from Malaysia (13) observed hypercalcemia in only one of 43 patients (2.3%). This difference could be due to dissimilar study populations from two different hospitals.

In addition to being hypoalbuminemic, patients with active TB commonly have protein and caloric deficiencies (1921). Hypoalbuminemia was present in 36% of patients with TB at admission in a study by Need et al (5), and in approximately two-thirds of patients in the present study at the time of diagnosis. In the present study, serum albumin correlated negatively with age and the extent of lung involvement in pulmonary TB. Similarly, in a study of pulmonary TB (11), a negative correlation was found between serum albumin and the extent of disease and with the extent of cavitation on chest radiography. The relatively high frequency of hypoalbuminemia among the series in the present study may have been related to malnutrition, which was mainly due to the low socioeconomic status of these patients plus chronic ill-health as a result of TB. If the serum calcium concentration is not corrected for a low serum albumin concentration, then hypercalcemia may not be recognized. However, correction for hypoalbuminemia is not ideal (15,22); a more accurate evaluation of pathological changes in serum calcium requires the measurement of ionized rather than total serum calcium. Hypergammaglobulinemia occurs in a substantial proportion of patients with active TB (23), and in the presence of concurrent hypoalbuminemia, giving rise to an increase in the globulin to albumin ratio, and a possible increase of globulin binding of calcium (24). Because 80% to 90% of protein-bound calcium is bound to albumin, the serum albumin concentration is more appropriate than the total serum protein concentration as the basis of adjustment of total serum calcium concentration (25). Payne et al (25) have shown that in patients with hypergammaglobulinemia, there is a better correlation of total serum calcium concentration with serum albumin concentration than with total serum protein concentration.

Hypercalcemia can be noted during the active phase of TB (13). The mechanism of hypercalcemia in these patients is not known, even though possible involvement of the bone by TB has been postulated as a cause. However, clinical evidence of bone involvement was present in only five patients in this series with hypercalcemia; specifically, five had spinal TB. The occurrence of hypercalcemia in TB patients may be related to the extent of disease, the intake of vitamin D and calcium, and the amount of sun exposure (69,11,17,26,27). Although Chan et al (9,10) and Need et al (5) reported a positive relationship between the pretreatment albumin-adjusted serum calcium concentrations and the severity (5) or extent (9,10) of chest radiography changes, the results of the present study did not show this to be so. Chan et al (8) reported no correlation between the extent of disease and serum calcium concentrations.

Abundant data from different studies (2832) indicate that extrarenal 1-alpha-hydroxylation of 25-hydroxycholecalciferol (25[OH]D3) to 1,25-dihydroxycholecalciferol (1,25[OH]2D3), the metabolically active form of vitamin D, plays an important role in causing hypercalcemia in patients with TB. High circulating levels of 1,25(OH)2D3 have been reported in anephric patients with TB (29,30), supporting the idea that extrarenal production of 1,25(OH)2D3 is important in producing these metabolites. Some cells, including cultured alveolar macrophages obtained by bronchoalveolar lavage from a patient with pulmonary TB, have been shown to produce 1,25(OH)2D3 (32). Macrophages probably play a critical role in the activation of vitamin D by 1-alpha-hydroxylation. Another study (33) showed the production of 1,25(OH)2D3 by T lymptocytes, possibly CD8+ T lymphocytes and alveolar macrophages recovered by bronchoalveolar lavage from patients with active TB.

TB patients with relatively high vitamin D levels have more circulating vitamin D available for extrarenal synthesis of 1,25(OH)2D3 than others. If calcium intake is high, gut absorption of calcium is also relatively high. Apart from ingestion, vitamin D3 (cholecalciferol) is synthesized from 7-dehydrocholesterol in the skin during exposure to ultraviolet light. The amount of sun exposure and the circulating levels of 25(OH)D3, a product of hydroxylation of vitamin D3 in the liver, may partly explain the rare occurrence of hypercalcemia in TB patients in countries with temperate climates (6,26).

This may also possibly explain why hypercalcemia is rare in TB patients in the United Kingdom (19) who have high calcium intake but low vitamin D levels. It has been reported (11) that in tropical climates, where sunlight is abundant, a relatively high level of serum 25(OH)D3 may give rise to hypercalcemia in patients with TB. Nigeria is in the tropical belt with abundant sunshine throughout the year, which may explain the relatively high incidence of hypercalcemia in the present series of patients with TB.

REFERENCES

  • 1.Braman SS, Glodman AL, Schwarz MI. Steroid-responsive hypercalcemia in disseminated bone tuberculosis. Arch Intern Med. 1973;132:269–71. [PubMed] [Google Scholar]
  • 2.Rook GA. The role of vitamin D in tuberculosis. Am Rev Respir Dis. 1988;138:768–70. doi: 10.1164/ajrccm/138.4.768. [DOI] [PubMed] [Google Scholar]
  • 3.Abbasi AA, Chemplavil JK, Farah S, Muller BF, Arnstein AR. Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med. 1979;90:324–8. doi: 10.7326/0003-4819-90-3-324. [DOI] [PubMed] [Google Scholar]
  • 4.Kitrou MP, Phytou-Pallikari A, Tzannes SE, Virvidakis K, Mountokalakis TD. Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med. 1982;96:255. doi: 10.7326/0003-4819-96-2-255. [DOI] [PubMed] [Google Scholar]
  • 5.Need AG, Phillips PJ, Chiu F, Prisk H. Hypercalcaemia associated with tuberculosis. Br Med J. 1980;280:831. doi: 10.1136/bmj.280.6217.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fuss M, Karmali R, Pepersack T, et al. Are tuberculosis patients at a great risk from hypercalcemia? Q J Med. 1988;69:869–78. [PubMed] [Google Scholar]
  • 7.Davies PD, Brown RC, Church HA, Woodhead JS. The effect of anti-tuberculosis chemotherapy on vitamin D and calcium metabolism. Tubercle. 1987;68:261–6. doi: 10.1016/0041-3879(87)90066-3. [DOI] [PubMed] [Google Scholar]
  • 8.Chan TY, Poon P, Pang J, et al. A study of the calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg. 1994;97:26–30. [PubMed] [Google Scholar]
  • 9.Chan TY, Chan CH, Shek CC, Davis PD. Hypercalcemia in active pulmonary tuberculosis and its occurrence in relation to the radiographic extent of disease. Southeast Asian J Trop Med Public Health. 1992;23:702–4. [PubMed] [Google Scholar]
  • 10.Chan TY, Chan CH, Shek CC. The prevalence of hypercalcaemia in pulmonary and miliary tuberculosis – a longitudinal study. Singapore Med J. 1994;35:613–5. [PubMed] [Google Scholar]
  • 11.Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis. 1987;71:341–4. [PubMed] [Google Scholar]
  • 12.Sharma SC. Serum calcium in pulmonary tuberculosis. Postgrad Med J. 1981;57:694–6. doi: 10.1136/pgmj.57.673.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tan TT, Lee BC, Khalid BA. Low incidence of hypercalcaemia in tuberculosis in Malaysia. J Trop Med Hyg. 1993;96:349–51. [PubMed] [Google Scholar]
  • 14.Liam CK, Lim KH, Srinivas P, Poi PJ. Hypercalcaemia in patients with newly diagnosed tuberculosis in Malaysia. Int J Tuberc Lung Dis. 1998;2:818–23. [PubMed] [Google Scholar]
  • 15.Pain RW, Rowland KM, Phillips PJ, Duncan BM. Current “corrected” calcium concept challenged. Br Med J. 1975;4:617–9. doi: 10.1136/bmj.4.5997.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Simon G. Radiology in epidemiological studies and some therapeutic trials. Br Med J. 1966;2:491–4. doi: 10.1136/bmj.2.5512.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chan CH, Chan TY, Shek AC, Mak TW, Lui SF, Lai KN. Severe hypercalcaemia associated with miliary tuberculosis. J Trop Med Hyg. 1994;97:180–2. [PubMed] [Google Scholar]
  • 18.Chan TY. Symptomatic hypercalcaemia is rare in tuberculosis patients in Hong Kong. Ann Trop Med Parasitol. 1996;90:663–4. doi: 10.1080/00034983.1996.11813100. [DOI] [PubMed] [Google Scholar]
  • 19.Onwubalili JK. Malnutrition among tuberculosis patients in Harrow, England. Eur J Clin Nutr. 1988;42:363–6. [PubMed] [Google Scholar]
  • 20.Harries AD, Nkhoma A, Thompson PJ, Nyangulu DS, Wirima JJ. Nutritional status in Malawian patients with pulmonary tuberculosis and response to chemotherapy. Eur J Clin Nutri. 1988;42:445–50. [PubMed] [Google Scholar]
  • 21.Bhave GG, Pathare AV, Dagha C, Chabria L, Dalvi SG. Immunoprofile of pulmonary tuberculosis-comparison with normal healthy controls. J Postgrad Med. 1989;35:24–9. [PubMed] [Google Scholar]
  • 22.Phillips PJ, Pain RW, Hartley TF, Duncan BM, Atkinson MJ. Current “corrected” calcium concept rechallenged. Clin Chem. 1977;23:1938–9. [PubMed] [Google Scholar]
  • 23.Onwubalili JK, Scott GM. Immune status in tuberculosis and response to treatment. Tubercle. 1988;69:81–94. doi: 10.1016/0041-3879(88)90070-0. [DOI] [PubMed] [Google Scholar]
  • 24.Siggaard-Andersen O, Thode J, Fogh-Andersen N. Nomograms for calculating the concentration of ionized calcium of human plasma from total calcium, total protein and/or albumin, and pH. Scand J Clin Lab Invest Suppl. 1983;165:57–64. [PubMed] [Google Scholar]
  • 25.Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4:643–6. doi: 10.1136/bmj.4.5893.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax. 1985;40:187–90. doi: 10.1136/thx.40.3.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Carroll N. Tuberculous hypercalcaemia with renal failure. Br J Dis Chest. 1987;81:296–9. doi: 10.1016/0007-0971(87)90165-3. [DOI] [PubMed] [Google Scholar]
  • 28.Isaac RD, Nicholson GI, Holdaway IM. Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax. 1987;42:555–6. doi: 10.1136/thx.42.7.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gkonos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med. 1984;311:1683–5. doi: 10.1056/NEJM198412273112607. [DOI] [PubMed] [Google Scholar]
  • 30.Felsenfeld AJ, Drezner MK, Llach F. Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis. Arch Intern Med. 1986;146:1941–5. [PubMed] [Google Scholar]
  • 31.Peces R, Alvarez J. Hypercalcemia and elevated 1,25(OH)2D3 levels in a dialysis patient with disseminated tuberculosis. Nephron. 1987;46:377–9. doi: 10.1159/000184506. [DOI] [PubMed] [Google Scholar]
  • 32.Cadranel J, Hance AJ, Milleron R, Paillard F, Akoun GM, Garabedian M. Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Respir Dis. 1988;138:984–9. doi: 10.1164/ajrccm/138.4.984. [DOI] [PubMed] [Google Scholar]
  • 33.Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest. 1990;85:1588–93. doi: 10.1172/JCI114609. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Respiratory Journal : Journal of the Canadian Thoracic Society are provided here courtesy of Wiley

RESOURCES